Horizon Kinetics spotlights six small-cap royalty and land firms with strategic exposure to resource scarcity and inflation.
Discover key Q3 2025 earnings insights for Travere Therapeutics, including FILSPARI sales growth, FDA milestones, and outlook for rare kidney ...
Get key insights from Columbia Sportswear’s Q3 2025 earnings: tariff impacts, U.S. sales trends, global growth, and strategic plans.
Discover Ardelyx's Q3 2025 earnings highlights: record IBSRELA growth, raised revenue guidance, new pipeline expansion, and strong long-term outlook.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback